Search all trials

Find therapies in clinical trials near you – page 49

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Paroxysmal nocturnal haemoglobinuria

Not recruiting

Registered drugNo placebo

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Crovalimab

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pirtobrutinib

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drug

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Rhabdomyosarcoma+4

Not recruiting

InvestigationalNo placebo

Study of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma

InvestigationalNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Lenvatinib

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Nilotinib

Contact Research Centre

Evaluating Higher Dose Nusinersen in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam

Not recruiting

InvestigationalNo placebo

Evaluating Higher Dose Nusinersen in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam

InvestigationalNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Nusinersen

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Study on Retreatment with Encorafenib and Cetuximab for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Not recruiting

Registered drugNo placebo

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Binimetinib

Contact Research Centre

Brain stem glioma

Not recruiting

Registered drugNo placebo

Study on Radiotherapy with Nimotuzumab and Vinorelbine for Newly Diagnosed Childhood and Adolescent Diffuse Intrinsic Pontine Glioma (DIPG) Patients

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Nimotuzumab

Contact Research Centre

Squamous cell carcinoma of skin

Not recruiting

Registered drug

Study of Cemiplimab Compared to Placebo After Surgery and Radiation for Patients with High-Risk Skin Squamous Cell Carcinoma

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Cevostamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cevostamab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Daratumumab with Drug Combination for Young Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Bortezomib

Contact Research Centre

Find therapies in clinical trials near you – page 49

676 trials match your criteria

Paroxysmal nocturnal haemoglobinuria

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Chronic lymphocytic leukaemia

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Systemic lupus erythematosus

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Rhabdomyosarcoma+4

Study of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma

Chronic myeloid leukaemia

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Evaluating Higher Dose Nusinersen in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam

Evaluating Higher Dose Nusinersen in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam

Colorectal cancer metastatic

Study on Retreatment with Encorafenib and Cetuximab for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Brain stem glioma

Study on Radiotherapy with Nimotuzumab and Vinorelbine for Newly Diagnosed Childhood and Adolescent Diffuse Intrinsic Pontine Glioma (DIPG) Patients

Squamous cell carcinoma of skin

Study of Cemiplimab Compared to Placebo After Surgery and Radiation for Patients with High-Risk Skin Squamous Cell Carcinoma

Plasma cell myeloma

Study on the Effectiveness and Safety of Cevostamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

Plasma cell myeloma

Study Comparing Daratumumab with Drug Combination for Young Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.